ESR1 and breast carcinoma: While tumor subgroups defined by high-risk features (e.g., low immunohistochemistry-based ER levels, low ESR1 expression, Basal-like subtype) showed enrichment for early-onset breast cancer, all of these categories and combinations thereof were best described by a two-component mixture model.